Objective-To investigate the molecular genetic basis of the cause of disease in a family with hypertrophic cardiomyopathy.
Echocardiography in 1977 showed classic features of hypertrophic cardiomyopathy. The left ventricular cavity was small (end diastolic dimension 48 mm) and contracted well (fractional shortening 38%). There was symmetrical septal hypertrophy. The septum was 26 mm thick (normal < 11 mm) and the posterior wall was 11 mm thick (normal < 11 mm). There was no significant left ventricular outflow tract gradient, nor was there systolic anterior motion of the mitral valve. At She was reviewed in 1989 because of an increasing diuretic requirement for progressive heart failure and was categorised as New York Heart Association class III. At the time the echocardiographic picture had changed. Although end diastolic dimensions were similar (49 mm) the end systolic dimensions had increased (38%) and fractional shortening had decreased to 22%. Ventricular septal thickness had also been reduced to 14mm with the posterior wall remaining unchanged at 11 mm.
The patient died in intractable heart failure aged 61 years. A postmortem examination confirmed bi-ventricular hypertrophy (most prominent in the septum) and bi-ventricular dilatation. Histological examination showed cardiac myocyte hypertrophy and variation in nuclear size with a considerable increase in fibrous tissue. There was no evidence of myocardial fibre disarray, though only a small amount of myocardium was available for review. The intramural coronary arteries appeared normal. These findings are consistent with, but not diagnostic of, hypertrophic cardiomyopathy.
The brother of the index case (III/3) died suddenly after strenuous exercise in 1953 at the age of 18 years. Postmortem examination showed left ventricular hypertrophy. Unfortunately, a histological examination was not available for review. The patient's mother, II/2, died aged 71 years and a diagnosis of hypertrophic cardiomyopathy was made at necropsy.
The index case (III/2) had two sons and one daughter: the daughter and one son are twins. Electrocardiographic examination of individual IV/1 showed abnormal Q waves in leads V3 and V4 and inverted or biphasic T waves in the inferior and lateral leads (I, II, III, aVL, and V6) (fig 2) . However, echocardiography was apparently normal with normal ventricular cavity dimensions and function. The interventricular septum was 11 mm and the posterior wall 10 mm (both within normal limits). These findings have not changed since 1989. This individual is currently symptom free: the abnormal elec- Members of generation V were also-included in this analysis (fig 4) . Individuals V/1 and V/2 are 13 and 12 years of age respectively and seem to be clinically normal. Digestion of the PCR product after amplification of exon 23 in V/2 showed that this individual has inherited the mutation from her father. Direct sequencing confirmed this result. Her sib showed no evidence of the mutation.
The Additional evidence to support the role of this mutation as the underlying genetic defect in this family was sought by segregation analysis of the affected chromosome ( fig 5) . We used a highly informative microsatellite sequence polymorphism identified in intron 24 of the MYH7 gene to reconstruct the genotype of individual III/2. Though the locus was not fully informative in all members of the pedigree, we were able to establish that this individual was heterozygous for alleles 3 and 4 of the polymorphism. Analysis of the pedigree indicates that the disease mutation is segregating with allele 4; the subsequent inheritance of the normal maternal chromosome (allele 3) by individuals IV/3 and IV/4 is consistent wi-th the absence of the mutation in these individuals.
Discussion
Hypertrophic cardiomyopathy is the commonest cause of sudden death in apparently healthy young people below the age of 30 years. 4 The disease seems to be present in most, if not all, racial groups with an incidence of approximately 1/5000 of the population. '6 In adults, the annual mortality rate is 2-3%, though children seem to be at greater risk with mortality as high as 6% per year. '7 The family described in this study illustrates many of the most difficult clitical challenges in the diagnosis and management of HCM.
Sudden death may be the first manifestation of HCM, as in the case seen in this family (III/3). Unconfirmed postmortem data indicated evidence of HCM on gross pathology. This man was doing National Service and as a member of the'-armed forces should have had medical examination to confirm a general state of good health. It is highly likely that investigation by modern diagnostic techniques would have resulted in an unequivocal diagnosis. However, other individuals have been described who have died suddenly without clinical evidence of the disease and with a normal histological appearance. In these cases, only patchy myocardial fibre disarray and the family history attest to the presence of HCM.'8 Early diagnosis, facilitated by the identification of a .pathogenetic mutation, would allow intervention with potentially lifesaving advice and treatment.
Many cases with an equivocal HCM phenotype are discovered during screening of first degree relatives of confirmed patients and the course in these patients is not known. Case IV/1 is a typical example. At 40 years of age, despite a grossly abnormal electrocardiogram consistent with HCM, he does not show ventricular hypertrophy. In the absence of a confirmed family history of HCM this would leave the diagnosis in doubt. However, the lack of gross morphological evidence of the disease does not indicate that the patient is free from the risk of sudden death. A genetic analysis dispels doubts and allows more effective delivery of medical care.
Children Though one member of the family died suddenly at an early age, the mutation causing HCM in this family seems to be associated with a relatively favourable prognosis. This is further supported by the findings in a recent preliminary report describing a similar mutation in a family in which sudden death was uncommon.2'22 This contrasts with the high incidence of premature sudden death associated with mutations in other exons of MYH7 which alter the net charge.'4 The mutation reported here does not change the net charge and therefore suggests that such events may give rise to a more benign phenotype that can be expressed as sudden death as the result of environmental factors such as strenuous exercise.
The substitution does, however, reduce hydrophobicity and occurs at the boundary region between the globular head of myosin and the rod region.2324 Evolutionary sequence comparison has shown that the leucine at position 908 is highly conserved across species from man to amoeba (table), which supports the evidence for the deleterious effect of the mutation in the molecule.
The striking clinical heterogeneity among patients with HCM is reflected by the considerable regional differences in ventricular hypertrophy and disarray. The mechanism by which a genetic mutation could lead to abnormalities in only some regions of the myocardium remains to be resolved, as does the question of the variable clinical penetrance within families.
Demonstration of the genetic basis for the condition is important for many reasons. Elucidation of the molecular genetics of the disease will aid in understanding the function of the contractile proteins of the heart, and thus the myocardial fibre disarray and hypertrophy in HCM. In turn this may suggest explanations of other processes that lead to ventricular hypertrophy. Knowledge of the underlying molecular disorder could rationalise therapy by identifying patients at high risk through more lethal mutations and by suggesting specific treatments. Ascertaining the contribution of other genes and environmental influences on the expression of mutations of the MYH7 gene will also be important in future therapeutic developments.
